BIO generates very strong cashflows considering their growth rate is so high. I assume they can acheive this becuase of their 59% plus margins. It appears that other than some minor debt, their sales growth is effectively self funding. Very impressive quarterly result with an even more ecouraging outlook.
- Forums
- ASX - By Stock
- BIO
- Ann: Quarterly Activities & Cashflow Report
Ann: Quarterly Activities & Cashflow Report, page-8
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.0¢ |
Change
0.030(5.88%) |
Mkt cap ! $116.3M |
Open | High | Low | Value | Volume |
53.5¢ | 55.0¢ | 52.5¢ | $402.4K | 748.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 41187 | 53.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 10702 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 41187 | 0.530 |
3 | 55262 | 0.525 |
1 | 50000 | 0.520 |
4 | 99533 | 0.515 |
12 | 243674 | 0.510 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 10702 | 2 |
0.545 | 6795 | 3 |
0.550 | 15889 | 2 |
0.555 | 10090 | 1 |
0.560 | 15007 | 1 |
Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |